NCT01724268View on ClinicalTrials.gov

Corticosteroids and Anti TNF in Methotrexate Inadequate Responder Rheumatoid Arthritis Patient

PHASE3UnknownINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

May 31, 2014

Study Completion Date

September 30, 2014

Conditions
RHEUMATOID ARTHRITIS
Interventions
DRUG

Pred + Meth

PREDNISOLONE 10mg orally ONCE DAILY and Methotrexate 25 mg / day

DRUG

Anti TNF + Meth

Trial Locations (1)

3050

RECRUITING

Hamad General Hospital, Doha

Sponsors
All Listed Sponsors
lead

Hamad Medical Corporation

INDUSTRY

NCT01724268 - Corticosteroids and Anti TNF in Methotrexate Inadequate Responder Rheumatoid Arthritis Patient | Biotech Hunter | Biotech Hunter